Le Lézard
Classified in: Health
Subjects: HEALTH, ANALYSTS' COMMENTS, MISCELLANEOUS, MISCELLANEOUS

Hearing Aids Market worth $10.2 billion by 2026 - Exclusive Report by MarketsandMarketstm


Northbrook, April 05, 2022 (GLOBE NEWSWIRE) -- According to the new market research report "Hearing Aids Market by Product Type [Aids (Receiver,Behind the Ear, In the Canal, In the Ear Aids), Implants (Cochlear, Bone-anchored)], Type of Hearing Loss (Sensorineural, Conductive), Patient Type (Adults, Pediatrics), Region - Global Forecast to 2026", published by MarketsandMarketstm, the global Hearing Aid Devices Market is projected to reach USD 10.2 billion by 2026 from USD 7.5 billion in 2021, at a CAGR of 6.4%.

Browse in-depth TOC on "Hearing Aids Market"
243 ? Tables
51 ? Figures
238 ? Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=198630754

The growing prevalence of hearing loss, the increasing adoption of smart hearing aids due to the rising incidence of noise-induced hearing loss, and technological advancements in hearing aids are among the major factors propelling the growth of this market. Emerging economies such as China, India, and Japan are providing lucrative opportunities for the players operating in the market.

The hearing aid devices segment accounted for the largest share of the market, by product segment, in 2020

Based on product, the hearing aids market is segmented into hearing aid devices and hearing implants. The hearing aid devices segment accounted for the largest share of the market in 2020. Factors such as the increasing number of product approvals, rising geriatric population, and increasing technological advancements in hearing aid devices are boosting the market growth of this segment.

Sensorineural hearing loss segment to register the highest growth rate during the forecast period

The hearing aids market is segmented into sensorineural hearing loss and conductive hearing loss. In 2020, the sensorineural hearing loss segment accounted for the highest growth rate. Factors such as the increase in the number of product approvals and the high prevalence of sensorineural hearing loss, coupled with the growing geriatric patient pool are contributing to the growth of this segment.

The adult patients segment accounted for the largest share of the hearing aids market, by patient type segment, in 2020

Based on patient type, the hearing aids devices market is segmented into adults and pediatrics. In 2020, the adult patients segment accounted for the largest share of the market. The growing incidence of hearing loss among the adult population is driving this segments growth.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=198630754

Europe is the largest regional market for hearing aids market

The global hearing aids devices market is segmented into five major regions-North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2020, Europe accounted for the largest share of the market. The large share of this region can be attributed to the rising geriatric population, the increasing incidence of hearing disorders, the rapid adoption of technologically advanced hearing aids, and the well-established healthcare industry.

The major players operating in this hearing aids device market are Sonova Group (Switzerland), Demant A/S (Denmark), GN Store Nord A/S (Denmark), Cochlear Ltd. (Australia), RION Co., Ltd. (Japan), Starkey (US), Nurotron Biotechnology Co., Ltd. (China), MED-EL (Austria), Audina Hearing Instruments, Inc. (US), Elkon Pvt. Ltd. (India), WS Audiology A/S (Denmark), Eargo, Inc. (US), Horentek (Italy), ZOUNDS Hearing Inc. (US), SeboTek Hearing Systems, LLC. (US), Arphi Electronics Private Limited (India), IN4 Technology Corporation (China), BHM-Tech Produktionsgesellschaft mbH (Austria), Nano Hearing Aids (US), LORECa s.r.o. (Turkey), Earlens Corporation (US), Austar Hearing Science and Technology (Xiamen) Co., Ltd. (China), Lively Hearing Corporation (US), audifon GmbH & Co. KG (Germany), and Foshan Vohom Technology Co., Ltd. (China).

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=198630754



These press releases may also interest you

at 16:54
Hondros College of Nursing (HCN) will introduce a new Medical Assisting program at its six Ohio campuses in 2024 to meet the growing need for medical assistants in a variety of settings.  According to the U.S. Bureau of Labor Statistics (BLS),...

at 16:45
Halozyme Therapeutics, Inc. ("Halozyme") today announced the election of Mahesh Krishnan, M.D. to its Board of Directors. Dr. Krishnan has more than 20 years of experience in healthcare, biotechnology and health services. "Mahesh is a dynamic and...

at 16:35
Geron Corporation , a late-stage clinical biopharmaceutical company, today announced that it will release its first quarter 2024 financial results and business highlights before the market opens on Thursday, May 2, 2024 via press release, which will...

at 16:35
Tilray Brands, Inc. , a leader in the craft beer and cannabis-lifestyle industries, celebrates high honors and awards at the 2024 Craft Brewer's Conference and World Beer Cup. 10 Barrel Brewing won four craft beer awards and 10...

at 16:34
Fusion Pharmaceuticals Inc. , a clinical-stage oncology company focused on developing next-generation radioconjucates (RCs) as precision medicines, today announced that it has filed and is in the process of mailing the management information circular...

at 16:30
In an important step toward driving long-term affordability and access to treatments for chronic and complex conditions, Evernorth Health Services announced that it will have a Humira® biosimilar available for $0 out of pocket for eligible...



News published on and distributed by: